I-Sight TM
Natural health product licensed in Canada
- Licence holder
- Xymogen
- NPN or DIN-HM
- 80042404
- Status
- Inactive licence
- Licence date
- 21 May 2013
- Revision date
- 23 January 2018
- Form
- Capsule
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Lycopène tout trans Source : Lycopène | 3 mg | Not calculated |
| Acide L-alpha-acétamido-bêta-mercaptopropionique Source : N-Acétyl-L-cystéine | 100 mg | Not calculated |
| Acide DL-alpha-lipoïque Source : Acide DL-alpha-lipoÏque | 75 mg | Not calculated |
Non-medicinal ingredients
Hypromellose, Cellulose microcristalline, Acide ascorbique, Stéarate de magnésium, NA, Gomme arabique
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | 1 Capsule | 1 day |
Uses authorised in Canada
A factor in the maintenance of good health. Helps in connective tissue formation. Helps to maintain healthy skin. Helps the body to metabolize carbohydrates, fats and proteins. Helps to maintain immune function. Provides antioxidants for the maintenance of good health. Antioxidant for the maintenance of good health. Antioxidant for the maintenance of eye health. Helps to maintain eyesight in conditions (associated with sunlight damage), such as cataracts and age-related macular degeneration. Helps to support eye health in conditions (associated with sunlight damage), such as cataracts and age-related macular degeneration. Helps to reduce the risk of developing cataracts. Helps to improve macular pigment optical density. An antioxidant.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Précautions et mises en garde
Consult a health care practitioner prior to use if you are pregnant or breastfeeding. Consult a health care practitioner prior to use if you have diabetes, cystinuria or if you are taking nitroglycerin or antibiotics. If you experience sweating, paleness, chills, headache, dizziness and/or confusion, discontinue use and consult a healthcare practitioner.
- Effets indésirables connus
Do not use if you are allergic to plants of the Asteraceae/Compositae/Daisy family.
Source
Official Health Canada record, licence 80042404
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).
List recorded in 2018. Photograph the packaging to check whether it has changed. Photograph the packaging